One product, one panel, one record.
Designs for Health FloraMyces, 60 vegetarian capsules (SKU FLM060) — label audit
The Supplement Facts panel declares milligrams and no CFU at all. For a live-organism product that is not a potency measure — dead cells weigh the same as live ones. The only count, "10 billion viable cells at the time of manufacture", appears in marketing prose, outside the panel where it would be binding.
This page is an audit of a label. It records what this product’s panel discloses, what of that could be checked against a primary record, and what could not. The score below ranks this product on that disclosure and on nothing else.
The record this page rests on
- NIH label record
- Label read on
- The most recent dated artefact behind this page. Labels change; this is how old our reading of it is.
- Cohort
- Addendum — outside the founding denominators Audited 2026-07-31, after the founding cohort of 27 was frozen. It sits outside every D27 denominator this site publishes.
- How deep this went
- Label audit — the lighter pass What the label says, what basis it gives for its CFU number, whether the strains are coded, whether a government label record exists — checked and published. No full claim inventory was written for this SKU. It is a real result, and it is a shallower one than the teardowns above it, which is why the page says so before you weigh it against them.
- What did not survive verification
- Part of this page was refuted or could not be reproduced The current panel on this page rests on one source, and the government record behind it is thirteen years old. Designs for Health publishes no Supplement Facts panel on its product pages in any form, so the current panel — the 2-capsule serving, the single 500 mg S. boulardii row, the other ingredients, and the absence of any CFU figure — comes from a single practitioner retailer's transcription. Its only cross-check is DSLD 22443, entered 2013-07-25, which carries no label scan at all (both its pdf and thumbnail fields are empty) and agrees with the retailer on the one figure it contains. That agreement across thirteen years is meaningful and it is not a second independent read of the current carton, so any statement here about what the physical panel prints today is bounded to those two surfaces. A second item, and it is the reason this SKU's potency classification needs reading carefully: this product has no CFU claim on its panel at all. The "10 billion viable cells at the time of manufacture" figure exists only in marketing prose on the brand page and in retailer descriptions. It is recorded here as an at-manufacture basis because that is what it says and because naming a moment is more than most of this category does — but it is prose, not panel, and it must never be quoted as a panel declaration. What did survive verification: the milligram-only panel, consistent between a 2013 government record and a current retailer transcription; the complete absence of a strain designator, with "Biootic" identified as a supplier trade name rather than a deposited culture; the price and SKU from the brand's own ld+json offer block; and the NSF/ANSI 173 negative read at the issuer's own register.
The Label Verifiability Score for this product
34.7 out of 100
Rank 112 of the 154 products in this audit the rubric can score.
The score measures one thing: how much of what you are buying this company tells you, and how much of that survives being checked against a source that is not the company. It does not measure whether the product works — this site holds no efficacy data of its own, and 0 of 294 organism slots in the founding cohort carry a strain with a human randomised trial for any male-specific outcome, so nobody in this category has evidence that would support a ranking by effect.
Computed over the whole rubric: this record answers all five questions below, so nothing is renormalised away and the divisor is the full 1.00. That share travels with every score on this site and is never dropped — a score over part of the rubric’s weight and the same score over all of it are different claims.
| Component | Weight | What was counted, and where | Fraction | Weight × fraction |
|---|---|---|---|---|
| Strain identity printed on the panel | 0.24 | 0 of 1 organism slot carries a printed strain designator. | 0 / 1 = 0.0000 | 0.0000 |
| Per-organism amount printed | 0.20 | 1 of 1 organism slot has an amount of its own; the rest are inside a blend total. | 1 / 1 = 1.0000 | 0.2000 |
| What the CFU count is measured against | 0.22 | Potency basis "at-manufacture": CFU figure printed yes, single basis stated yes, basis reaches expiry no — 2 of 3. | 2 / 3 = 0.6667 | 0.146667 |
| Printed designators that lead to a human trial | 0.20 | 0 of 1 checked organism slot resolves to at least one human randomised trial under the designator exactly as printed. This counts whether the identity leads to a trial, never what the trial found. | 0 / 1 = 0.0000 | 0.0000 |
| Certification confirmed at the issuer’s own register | 0.14 | 1 claimed certification queried at the issuer’s register and not listed there. | 0 / 1 = 0.0000 | 0.0000 |
0.346667 — the last column added up — divided by 1.00, the weight this record could answer, is 0.3467. Multiplied by 100 and rounded to one decimal, that is the 34.7 above.
See this product’s row in the full ranking, alongside the other 153 scored products, or read what each of the five components asks and how to check it .
What this label discloses
Everything in this table is what the product itself states — on the printed panel, on the brand’s own page, or in the label record the manufacturer filed. Nothing in it is checked yet; checking is the next section.
| Disclosure | As recorded |
|---|---|
| CFU as printed | No CFU figure recorded |
| What that count is measured against | At manufacture only |
| Strain designators | None — species only |
| Organism slots transcribed here | 1 — the full panel |
| Marketed as | Unisex |
"10 billion viable cells at the time of manufacture" — and this figure appears only in marketing prose, in the page body and in retailer descriptions. The Supplement Facts panel declares "Saccharomyces boulardii — 500 mg" and no CFU figure of any kind, and DSLD 22443 records the same single milligram row. The basis statement is the honest kind in that it names a moment — at manufacture is the weaker of the two bases, and it is disclosed — and it sits outside the regulated panel, so the product simultaneously deserves credit for saying when it counts and criticism for not putting the count where it is binding. Recorded as at-manufacture on that basis, with the caveat that the claim is prose, not panel. Storage: the product is marketed as shelf-stable with no refrigeration required.
The panel’s own words on potency, verbatim.
The count is stated at time of manufacture only. The panel makes no commitment about what is alive when you swallow it.
The panel names species only, with no strain designator anywhere. A species name is not a claim: the trials in this field are of strains, and a species can contain thousands.
| Organism as printed | Designator as printed | Quantity as printed | What the designator resolves to | The query we ran |
|---|---|---|---|---|
| Saccharomyces boulardii (correct name: Saccharomyces cerevisiae var. boulardii) | — none printed | 500 mg per 2-capsule serving | No designator printed | — |
What of that is verifiable
A disclosure is verifiable when a reader can open a record that neither we nor the brand controls and see the same thing. Below is every dated artefact this page rests on. What is absent from this list is not verified, however reasonable it sounds.
- NIH Dietary Supplement Label Database record — DSLD 22443 (opens in a new tab) captured On market, UPC 8 79452 00194 7, product version FLM060-1 — which matches the live ld+json SKU FLM060 exactly, and is what fixes the record to this product. Its scope limit is stated on the page it supports: the record is 13 years old and carries no label scan, with both pdf and thumbnail fields empty. It agrees with the current retailer panel on the one figure it contains — "Saccharomyces boulardii lyo — 500 mg" — and it confirms the panel has been milligram-only since 2013.
- Dated capture of the brand’s own page — dfh-floramyces-pdp-2026-07-31https://www.designsforhealth.com/products/floramyces — Address given, not linked: this site does not link out to the products it audits. captured Fetched directly, HTTP 200. Source for the price and SKU from the page's own ld+json offer block, for the "Saccharomyces boulardii as Biootic" wording, for the "10 billion viable cells at the time of manufacture" claim in body copy, for the mechanism section's sIgA and barrier-integrity claims, and for the shelf-stable positioning. It is also an artefact behind a finding: the page carries no Supplement Facts panel in any form.
- Dated capture of the brand’s own page — floramyces-retailer-transcription-psc-2026-07-31 captured A single practitioner retailer, Professional Supplement Center, reproducing the current panel as text — the only current transcription available, because the brand publishes no panel and the government record is 13 years old with no scan. Source for the 2-capsule serving size, the single 500 mg S. boulardii row, and the other-ingredients list (microcrystalline cellulose, capsule of hypromellose and water). Recorded without a URL on purpose: the audit records this retailer by name and by reachability rather than by address, and this project does not reconstruct a URL it did not fetch.
How many of its strains have a human trial for what it is sold for
Across the frozen founding cohort, 0 of 294 organism slots (0.0%) carry an organism with a human randomised controlled trial for any male-specific outcome. Not for this product — for all 27 of the founding teardowns, taken together. That is the number to hold against any men’s probiotic, including this one.
Two further founding-cohort figures for context: only 43 of 294 organism slots carry a strain with any human RCT at all under the exact code printed on the label, and only 2 of 27 products have a published human trial of the finished formula — the thing actually in the bottle. All three figures divide by the frozen cohort of 27 teardowns and 294 organism slots, never by every teardown on this site.
For this product specifically, 0 organism slots carry a strain with a human RCT under the exact designator printed on the label.
A word on what a designator has to clear before it counts here. The organism must be named with the exact strain code that appears in the trial, the trial must be in humans, and the code must return that trial when a reader searches it. A species name does not qualify: the trials in this field are of strains, and a species contains thousands of them.
What it costs per day
$1.80 a day at the dose the label itself instructs.
- Price
- $53.99 USD
- What that buys
- 60-capsule bottle (30 servings, 2 capsules daily), SKU FLM060
- Price checked
- — the source we read it fromhttps://www.designsforhealth.com/products/floramyces — Address given, not linked: this site does not link out to the products it audits.
What certification it holds, checked at the issuer’s own register
A badge on a bottle is a claim like any other. Every row below was checked — or not checked — at the certifier’s own public register, never at the badge. Across the frozen founding cohort, 2 of 27 products hold a certification we could confirm at the issuer — a founding-cohort figure, not a count over every teardown on this site.
| Programme | Status at the issuer | Checked |
|---|---|---|
| NSF/ANSI 173 contents certification | Absent from register | 31 July 2026 |
| Per-batch certificate of analysis | Brand-asserted, unverified | 31 July 2026 |
NSF/ANSI 173 contents certification
The register was queried and this product is not listed on it.
Verified at the issuer's own register. Designs for Health is listed with exactly one certified product, "Pro Greens + Reds". FloraMyces is not NSF contents-certified. No certification mark is claimed on this product, so this is a plain negative rather than a caught false claim.
Per-batch certificate of analysis
The badge is displayed, but the register could not be reached to confirm it. We call this unverified, not false.
Available by phone request only, in common with the great majority of this brand's catalogue. The brand's own certificate-of-analysis page asserts universal third-party batch verification while publishing lot-linked documents for only a handful of SKUs. Recorded as unverified rather than refuted: no phone call was made.
How it differs from the same brand’s women’s version
Across the fourteen same-brand men’s-versus-women’s label diffs run inside the frozen founding cohort, zero men’s or default formulas contain a probiotic strain, identified by designator, that was selected on male-specific evidence. In eight of the fourteen the sex-specific differentiator is a botanical or a mineral, and in five of the fourteen the women’s SKU is better-specified, cheaper, or both — “better-specified” meaning the panel that discloses more, never the panel with more in it. The rule behind each of those counts, and all fourteen pairs classified against it , are published in full. Diffs run on teardowns added since sit outside this fourteen, and outside the sentence above.
This brand sells no women’s counterpart to this product, so there is no diff to run.
Every finding on this page, with the record behind it
Finding 1 the-panel-discloses-milligrams-and-not-cfu
For a live-organism product, milligrams of biomass are not a potency measure — dead cells weigh the same as live ones. This is the one product in its batch where the Supplement Facts panel gives the buyer no potency figure at all.
The record: Panel transcription, 2026-07-31; DSLD 22443 records the same single row, "Saccharomyces boulardii lyo — 500 mg" — open it (opens in a new tab)
Finding 2 the-only-count-lives-outside-the-regulated-panel
"10 billion viable cells at the time of manufacture" appears in page body copy and retailer descriptions and not on the Supplement Facts panel. The basis is the honest kind in that it names a moment; it is stated where it does not bind.
The record: designsforhealth.com/products/floramyces body copy versus the panel as transcribed and as recorded at DSLD 22443, all 2026-07-31 — open ithttps://www.designsforhealth.com/products/floramyces — Address given, not linked: this site does not link out to the products it audits.
Finding 3 no-strain-designator-on-a-product-whose-rationale-is-strain-specific
The page's mechanism section cites S. boulardii's effects on secretory IgA, short-chain fatty acid production and barrier integrity. That literature is large — 126 randomised-trial-tagged records — and dominated by CNCM I-745. This label names no strain, so the product cannot be tied to any of it. "Biootic" is a supplier trade name, not a deposit.
The record: designsforhealth.com/products/floramyces mechanism section and "as Biootic" wording, against the panel, 2026-07-31 — open ithttps://www.designsforhealth.com/products/floramyces — Address given, not linked: this site does not link out to the products it audits.
Finding 4 at-manufacture-basis-on-a-shelf-stable-product
The product is explicitly marketed as needing no refrigeration, and the only potency moment it names is the moment of manufacture. The buyer carries the full decay risk from manufacture to consumption, with no expiry-dated floor anywhere on the label.
The record: designsforhealth.com/products/floramyces storage positioning and at-manufacture wording, 2026-07-31 — open ithttps://www.designsforhealth.com/products/floramyces — Address given, not linked: this site does not link out to the products it audits.
Finding 5 a-two-capsule-serving-doubles-the-computed-cost
The serving is 2 capsules per day, so the 60-capsule bottle is 30 servings and $1.80 a day. A buyer who assumes one capsule daily will compute half the true cost.
The record: designsforhealth.com ld+json offer block, $53.99, SKU FLM060; panel serving size 2 capsules, 2026-07-31 — open ithttps://www.designsforhealth.com/products/floramyces — Address given, not linked: this site does not link out to the products it audits.
Finding 6 not-nsf-certified-while-the-brand-holds-one-nsf-listing
Designs for Health is listed at NSF with exactly one certified product, Pro Greens + Reds. FloraMyces is not on the register, and claims no certification, so this is a plain negative.
The record: info.nsf.org/Certified/Dietary/Listings.asp queried for Designs for Health, 2026-07-31 — open it (opens in a new tab)
What we could not verify
Every gap below is published rather than deleted. Most are derived automatically from the empty fields in this page’s own record, so a gap cannot be hidden by leaving a box blank.
- The CFU figure on the panel
- No CFU figure was recorded for this product. Either the panel prints none or it was not transcribed; this teardown does not yet distinguish between the two.
- Per-batch certificate of analysis status
- Available by phone request only, in common with the great majority of this brand's catalogue. The brand's own certificate-of-analysis page asserts universal third-party batch verification while publishing lot-linked documents for only a handful of SKUs. Recorded as unverified rather than refuted: no phone call was made.
- Any CFU figure on the panel
- None exists. The Supplement Facts panel declares 500 mg of S. boulardii and no potency figure at all. The 10 billion viable cells claim lives in page body copy and retailer descriptions, outside the regulated panel. This is the one product in its batch where the panel gives a buyer no potency figure whatsoever.
- Which strain of S. boulardii is in the capsule
- Not disclosed. "Biootic" is a supplier or ingredient trade name, not a deposited culture identifier. The clinical literature for this organism is dominated by CNCM I-745, and nothing on this label ties the product to it.
- A current government transcription of this label
- DSLD 22443 exists and is 13 years old — entered 2013-07-25 — and carries no label scan at all: both its pdf and thumbnail fields are empty. It agrees with the current retailer panel on the one figure it contains, and it is not a current independent transcription.
- A second independent transcription of the current panel
- The current panel published here rests on a single practitioner retailer's reproduction, cross-checked only against the 13-year-old government record. The brand publishes no panel of its own in any form.
How to check every line of this page yourself
Nothing on this page requires trusting us. Every claim above resolves to a record you can open:
- Open the NIH Dietary Supplement Label Database record linked at the top of this page. It is the label the manufacturer filed, not our transcription of it.
- Compare the CFU line and the suggested-use line against the disclosure table above. If they disagree with us, we are wrong and we want to know.
- Take any strain designator from the panel and run the query printed beside it. The query is published precisely so you can get a different answer than we did.
- Divide the price by the number of days the label’s own dose instructions make the container last. That arithmetic is the whole of the cost-per-day row.
- Search the certifier’s own register for this product, not for the brand. A company can participate in a programme without this product being on its list.
The whole active panel is one line:
Saccharomyces boulardii — 500 mg
That is milligrams. For a live-organism product, milligrams of biomass are not a potency measure — dead cells weigh exactly as much as live ones. This is the one product in its batch whose Supplement Facts panel gives a buyer no potency figure at all, and the government record confirms it has been that way since 2013.
There is a count. It reads “10 billion viable cells at the time of manufacture” — and it lives in marketing prose, in the page body and in retailer descriptions, not on the panel. That produces an unusual result worth naming in both directions. Saying “at the time of manufacture” is the honest thing to do: it names a moment, which roughly half this category refuses to do at all. At-manufacture is the weaker of the two bases, and disclosing it is still disclosure. And it is stated where it does not bind. The product deserves credit for saying when it counts and criticism for not putting the count where the count would be enforceable.
The second gap is the strain.
There is no designator. The page calls the organism “Saccharomyces boulardii as Biootic” — and Biootic is a supplier trade name, not a deposited culture identifier. It does not do what CNCM I-745 does. That matters more here than for a multi-strain blend, because the page’s own mechanism section leans on S. boulardii’s effects on secretory IgA, short-chain fatty acids and barrier integrity, and that literature — 126 randomised-trial-tagged records — is dominated by CNCM I-745. Nothing on this label ties this product to any of it. (Worth adding: S. boulardii is not a separate species but conventionally S. cerevisiae var. boulardii, so the label arguably does not reach species level either.)
Two practical notes. The serving is two capsules, so the 60-count bottle is thirty days at $1.80 a day — a buyer assuming one a day computes half the real cost. And the at-manufacture basis sits on a product explicitly marketed as shelf-stable with no refrigeration, which means the buyer carries the entire decay curve from the factory to the last capsule, with no expiry-dated floor anywhere.